Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.

[1]  H. Moch,et al.  Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx , 2011, International journal of cancer.

[2]  Jay W. Shin,et al.  Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin. , 2010, The American journal of pathology.

[3]  J. Bagan,et al.  Oral cancer: clinical features. , 2010, Oral oncology.

[4]  C. Nutting,et al.  Advances in chemotherapy for head and neck cancer. , 2010, Oral oncology.

[5]  W. Westra,et al.  Lymphoepithelial-like Carcinoma of the Oropharynx: A Morphologic Variant of HPV-related Head and Neck Carcinoma , 2010, The American journal of surgical pathology.

[6]  D. Ribatti,et al.  Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study. , 2010, Histology and histopathology.

[7]  A. Negassa,et al.  Validation of the Histologic Risk Model in a New Cohort of Patients With Head and Neck Squamous Cell Carcinoma , 2010, The American journal of surgical pathology.

[8]  U. Drebber,et al.  Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations , 2010, Virchows Archiv.

[9]  Jordi Giralt,et al.  Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. , 2010, The Lancet. Oncology.

[10]  Y. Doki,et al.  Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma , 2010, Annals of Surgical Oncology.

[11]  S. Shukla,et al.  Prognostic significance of molecular markers in oral squamous cell carcinoma: A multivariate analysis , 2009, Head & neck.

[12]  Y. Shimada,et al.  Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung , 2009, Cancer science.

[13]  Edward S. Kim,et al.  ΔNp63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with Leukoplakia , 2009, Clinical Cancer Research.

[14]  R. Ewers,et al.  Preoperative radiochemotherapy in the treatment of advanced oral cancer: outcome of 276 patients. , 2009, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[15]  C. Chiang,et al.  Expression of BCL10 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. , 2009, Oral oncology.

[16]  T. Ettl,et al.  Outcome and Histopathologic Regression in Oral Squamous Cell Carcinoma after Preoperative Radiochemotherapy , 2009, Strahlentherapie und Onkologie.

[17]  Ziv Gil,et al.  Current concepts in management of oral cancer--surgery. , 2009, Oral oncology.

[18]  C. Scully,et al.  Oral squamous cell carcinoma overview. , 2009, Oral oncology.

[19]  J. Woolgar,et al.  Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. , 2009, Oral oncology.

[20]  H. Müller-Hermelink,et al.  Lymphangiosis carcinomatosa in squamous cell carcinomas of larynx and hypopharynx – value of conventional evaluation and additional immunohistochemical staining of D2-40 , 2009, World journal of surgical oncology.

[21]  James S. Brown,et al.  Survival following primary surgery for oral cancer. , 2009, Oral oncology.

[22]  J. Pammer,et al.  Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy. , 2009, International journal of radiation oncology, biology, physics.

[23]  J. Woolgar,et al.  Determinants of outcome following surgery for oral squamous cell carcinoma. , 2009, Future oncology.

[24]  Shaji Thomas,et al.  The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer. , 2008, Oral oncology.

[25]  H. Burke.  The power of prediction , 2008, Cancer.

[26]  M. Kojima,et al.  Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431. , 2008, Biochemical and biophysical research communications.

[27]  M. Carrozzo,et al.  Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[28]  W. Lydiatt,et al.  Staging of head and neck cancers: Is it time to change the balance between the ideal and the practical? , 2008, Journal of surgical oncology.

[29]  Edward S. Kim,et al.  Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  C. Chiang,et al.  Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[31]  J. Mühling,et al.  Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients. , 2007, Oral oncology.

[32]  H. Eich,et al.  Neoadjuvant Radiochemotherapy and Radical Resection for Advanced Squamous Cell Carcinoma of the Oral Cavity , 2008, Strahlentherapie und Onkologie.

[33]  I. Semba,et al.  Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma , 2007, Cancer.

[34]  R. Nason,et al.  The clinical significance of the positive surgical margin in oral cancer. , 2007, Oral oncology.

[35]  F. Neukam,et al.  [Five year survival of patients with primary oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study]. , 2007, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[36]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[37]  G. Christofori,et al.  The potential role of podoplanin in tumour invasion , 2006, British Journal of Cancer.

[38]  D. Megías,et al.  Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition , 2006, Journal of Cell Science.

[39]  Diane D. Liu,et al.  Overexpression of podoplanin in oral cancer and its association with poor clinical outcome , 2006, Cancer.

[40]  G. Colella,et al.  HPV infection in relation to OSCC histological grading and TNM stage. Evaluation by traditional statistics and fuzzy logic model. , 2006, Oral oncology.

[41]  Artur Ferreira,et al.  Oral squamous cell carcinoma: review of prognostic and predictive factors. , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[42]  E. Harris,et al.  Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation , 2006, Modern Pathology.

[43]  G. Christofori,et al.  Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. , 2006, Cancer cell.

[44]  J. Woolgar,et al.  Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. , 2006, Oral oncology.

[45]  R. Ji.  Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics , 2006, Cancer and Metastasis Reviews.

[46]  J. Woolgar,et al.  A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens. , 2005, Oral oncology.

[47]  M. van Glabbeke,et al.  Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) , 2005, Head & neck.

[48]  T. Sun,et al.  Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications. , 2005, Biochimica et biophysica acta.

[49]  G. Glinsky,et al.  Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. , 2005, The Journal of clinical investigation.

[50]  M. Quintanilla,et al.  Characterization of human PA2.26 antigen (T1α–2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas , 2005, International journal of cancer.

[51]  M. Clarke,et al.  Self-renewal and solid tumor stem cells , 2004, Oncogene.

[52]  J. Jacobs,et al.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.

[53]  F. Kainberger,et al.  Neoadjuvant radiochemotherapy of oral cavity and oropharyngeal cancer: evaluation of tumor response by ct differs from histopathologic response assessment in a significant fraction of patients , 2004, Head & neck.

[54]  B. Das,et al.  Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. , 2003, Oral oncology.

[55]  T. Paavonen,et al.  Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions , 2002, Virchows Archiv.

[56]  J. Giralt,et al.  Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx , 2000, Cancer.

[57]  T. Kirita,et al.  Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results. , 1999, Oral oncology.

[58]  J. Mühling,et al.  Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up). , 1994, International journal of oral and maxillofacial surgery.

[59]  G. Slotman,et al.  Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer five‐year results with impressive complete response rates and high survival , 1992, Cancer.

[60]  N. Gritzmann,et al.  Combined modality treatment of advanced cancers of the oral cavity and oropharynx. , 1991, International journal of radiation oncology, biology, physics.

[61]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .